At a glance
- Name: VialVerdict
- Website: vialverdict.com
- Category: Independent peptide vendor reviews and ratings.
- Founded: April 2026.
- Coverage: 16 peptide vendors, 65 peptides, cross-vendor product reviews anchored to the (vendor, peptide) pair.
- Business model: Independent and non-commercial during launch. VialVerdict does not currently earn affiliate commission and is not paid by any listed vendor. Founder-funded. May activate affiliate partnerships after the site reaches 100+ verified reviews or 1,000 daily visitors.
What VialVerdict is
VialVerdict is an independent review platform for peptide vendors. It aggregates verified buyer reviews across four rating dimensions (effectiveness, shipping speed, price, customer service) plus an overall score, and surfaces the data on vendor profile pages, peptide comparison pages, and per-product (vendor + peptide) review pages.
The platform exists because the existing options for peptide vendor research are vendor-owned blogs, scattered Reddit threads, and private forums — none of which are structured, comparable, or easy to find. VialVerdict treats peptide vendors the way G2 treats software vendors: structured, sortable, with rating history.
How reviews are verified
- Email verification. Every first-party review must reach a verified email before it goes live. The check is enforced in the database, not just the form.
- Verified buyer status. A reviewer is marked "verified buyer" when their email confirms AND the same email completed an affiliate-tracked click to that vendor before submitting the review.
- Imported reviews are clearly labeled. When VialVerdict imports a review from Reddit, YouTube, or a peptide forum, the review wears a provenance badge under the title showing source, original handle, publish month, and a link back to the source post.
- Rate limits. One review per (vendor, email) per 90 days, enforced at the database level.
- FTC compliance. Synthetic placeholder reviews are structurally prohibited. The database CHECK constraint rejects any review row that is neither a first-party row with a verified user nor a clearly-labeled imported row with a public source URL. This complies with the FTC Final Rule on Fake Reviews and Testimonials, effective October 2024.
How VialVerdict makes money
VialVerdict is currently independent and non-commercial. The site does not earn affiliate commission on outbound vendor clicks and is not paid by any listed vendor. The founder funds the site out of pocket during the launch phase to keep reviews and rankings unambiguously independent.
Affiliate partnerships may be activated once the site reaches 100+ verified reviews or 1,000 daily visitors. If and when that happens, this page and the affiliate disclosure will be updated to list every active program and commission rate. The ranking algorithm and review data will not change. Vendors with no affiliate program will continue to be ranked the same way as vendors with a generous one.
Full disclosure: vialverdict.com/affiliate-disclosure.
What VialVerdict covers
- Vendors: 19 peptide vendors as of May 2026, including Apollo Peptide Sciences, Soma Chems, Limitless Life, Particle Peptides, Modern Aminos, Pharma Lab Global, Skye Peptides, Swiss Chems, Sports Technology Labs, Behemoth Labs, Researched Peptides, Pharma Grade AU, Blue Sky Peptide, Ascension Peptides, EZ Peptides, Royal Peptides, Glacier Aminos, Onyx Bio Labs, and Prime Performance Peptides.
- Peptide categories: recovery and healing (BPC-157, TB-500), GLP-1 weight loss (Tirzepatide, Semaglutide, Retatrutide), growth hormone secretagogues (Ipamorelin, CJC-1295, Sermorelin), anti-aging mitochondrial peptides (NAD+, Epithalon, MOTS-c, SS-31), Khavinson bioregulators, skin and aesthetic peptides (Melanotan, GHK-Cu), and others.
- Total peptides: 65 peptides catalogued across vendors as of May 2026.
What VialVerdict does not do
- VialVerdict does not provide medical advice. The peptides listed are sold for research purposes only in most jurisdictions.
- VialVerdict does not sell peptides directly. It is a review platform that links to independent vendors.
- VialVerdict does not edit or rewrite review content submitted by users. It filters spam and removes content that violates the published trust guidelines, but does not change wording.
Regulatory context
The FDA opened a consultation in July 2026 to reclassify 14 peptides for legal use in the US. The peptide market is in a structural shift from the gray market into mainstream legal compounding. VialVerdict tracks vendor practices that will matter most as the market formalises: third-party HPLC publication, customs and shipping reliability, and customer service track record.
Contact and key pages
- Email: josh@vialverdict.com
- About: vialverdict.com/about
- How it works: vialverdict.com/how-it-works
- Trust guidelines: vialverdict.com/trust-guidelines
- Affiliate disclosure: vialverdict.com/affiliate-disclosure
- Machine-readable brand data: vialverdict.com/.well-known/brand-facts.json